Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 925

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 5
Chunk 925
---
    Operating expenses: 

    Research and development 
     3,618,796  
     3,517,093  
     101,703  
     3%
  
    General and administrative 
     1,392,709  
     1,046,854  
     345,855  
     33%
  
    Legal and professional 
     2,684,665  
     1,328,435  
     1,356,230  
     102%
  
    Total operating expenses and loss of operations 
     7,696,170  
     5,892,382  
     1,803,788  
     31%

    Other income (expense): 

    Interest expense - related parties 
     (8,692) 
     (6,825) 
     (1,867) 
     27%
  
    Interest expense 
     (1,198,738) 
     (2,484,193) 
     1,285,455  
     (52)%
  
    Interest income 
     38,138  
     79,117  
     (40,979) 
     (52)%
  
    Finance fee 
     (152,726) 
     (104,245) 
     (48,481) 
     47%
  
    Change in fair value of derivative liabilities 
     555,789  
     2,216,488  
     (1,660,699) 
     (75)%
  
    Change in fair value of convertible notes 
     122,553  
     —  
     122,553  
     —%
  
    Gain on sale of marketable securities 
     28,550  
     4,970  
     23,580  
     474%
  
    Change in fair value of marketable securities 
     — 
     71,568  
     (71,568) 
     (100)%
  
    Loss on settlement of convertible debt 
     (833,501) 
     (477,221) 
     (356,280) 
     75%
  
    Total other expense 
     (1,448,627) 
     (700,341) 
     (